AstraZeneca Pharma India gets DCGI nod to market diabetes drug News News / News 6 years ago 462 Views comments The product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca Pharma Ind... Read more
News Indian ADRs: Infosys, HDFC Bank, Dr Reddy#39;s Labs fall; Tata Motors gains News / News - 6 years ago
News 'Got phone calls from Lalu's men': Fodder scam judge after sentencing postponed for 2nd day in a row News / News - 6 years ago
Comments